STSS - Sharps Technology Inc
0.0169
-0.003 -18.343%
Share volume: 76,008,008
Last Updated: 04-08-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.02
0.00
-0.16%
Fundamental analysis
11%
Profitability
0%
Dept financing
17%
Liquidity
12%
Performance
20%
Performance
5 Days
-34.50%
1 Month
-96.16%
3 Months
-99.18%
6 Months
-89.06%
1 Year
-94.88%
2 Year
-98.63%
Key data
Stock price
$0.02
DAY RANGE
$0.01 - $0.02
52 WEEK RANGE
$0.01 - $4.16
52 WEEK CHANGE
-$95.01
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
Company detail

CEO: Robert M. Hayes
Region: US
Website: sharpstechnology.com
Employees: 3
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Region: US
Website: sharpstechnology.com
Employees: 3
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Sharps Technology Inc. researches, designs, develops, manufactures, distributes, and sells safety syringe products. Sharps Provensa is an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Recent news
